Shelter Pharma Limited Achieves A+ Rating in FSSAI Third-Party Food Safety Audit
Shelter Pharma Limited's manufacturing facility has achieved an A+ rating in a third-party food safety audit conducted under FSSAI regulatory framework. The facility scored 81/86 (94%) in the comprehensive evaluation, demonstrating strong compliance with food safety standards and regulatory requirements. This achievement reflects the company's commitment to maintaining high-quality manufacturing standards and robust safety protocols.

*this image is generated using AI for illustrative purposes only.
Shelter Pharma Limited has successfully completed a third-party food safety audit under the Food Safety and Standards Authority of India (FSSAI) regulatory framework, achieving exceptional results that underscore the company's commitment to quality and safety standards.
Audit Results and Performance
The manufacturing facility of Shelter Pharma Limited underwent a comprehensive evaluation by an FSSAI-recognized third-party auditing agency. The audit was designed to assess compliance with applicable food safety standards and regulatory requirements across the company's operations.
| Parameter: | Details |
|---|---|
| Audit Score: | 81/86 (94%) |
| Rating Achieved: | A+ |
| Regulatory Authority: | Food Safety and Standards Authority of India |
| Auditing Agency: | FSSAI recognized Third Party Auditing Agency |
| Facility Audited: | Manufacturing Facility of Shelter Pharma Limited |
Compliance and Quality Standards
The audit results demonstrate Shelter Pharma's strong adherence to prescribed food safety management systems and operational standards. The A+ rating reflects the facility's comprehensive compliance with FSSAI requirements and indicates the company's robust quality control measures.
The evaluation covered various aspects of food safety protocols, including:
- Manufacturing processes and procedures
- Quality control systems
- Regulatory compliance frameworks
- Operational safety standards
Regulatory Disclosure
Shelter Pharma Limited made this disclosure pursuant to Regulation 30 read with Schedule III – Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company informed the Bombay Stock Exchange Limited about the audit completion and results on March 18, 2026.
The successful audit outcome reinforces Shelter Pharma's dedication to maintaining high standards of quality and food safety in its products, positioning the company favorably within the regulatory compliance landscape.
Historical Stock Returns for Shelter Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.44% | -0.68% | -19.15% | -34.04% | -18.70% | -30.05% |
How might this A+ FSSAI rating impact Shelter Pharma's ability to secure new distribution partnerships or expand into international markets?
Will this exceptional audit score enable Shelter Pharma to command premium pricing for its products compared to competitors with lower safety ratings?
What potential regulatory advantages could this A+ rating provide if FSSAI introduces stricter compliance requirements for pharmaceutical manufacturers?


































